Retrotransposon sequences make up a significant portion of genomes in virtually all eukaryotes, and are actively propagating in the genomes of mice and men. Retrotransposons and their hosts represent complex networked systems at several levels. These include: 1) Mechanism of replication. Retrotransposon sequences encode no to few proteins, and thus interact with many host cell encoded proteins during the 'life cycle'of their propagation. These tap into pathways existing in the host for other purposes, to achieve the mechanistic steps involved in replicating their genome and inserting it into host genomic DNA. A myriad of host proteins also counter transposable element insertions and must be evaded or overwhelmed by retrotransposons. Systems biology approaches can be used to describe relationships between these physical interactors. 2) Targeting. Each phosphodiester bond in the genome represents a potential target for insertion of a transposon sequence, and yet every type of transposable element has some degree of preferential targeting at distinct levels of genomic organization. Sequences themselves, DNA modifications and chromatin structure, host proteins binding sites, and perhaps three dimensional positioning in the nucleus may all play roles in determining insertion site preference. These system level questions merit renewed consideration that exploit new high throughput methods for identifying retrotransposon insertion sites. 3) Cell-type specific limits to insertion. We will also focus on a very challengin - and medically relevant - systems level question to answer: how cell type specific interactions between mammalian hosts and LINE-1 retrotransposon specifically impact human health and disease. We will delineate how specific cellular environments resist or become hospitable for transposition, and approach questions like 'Why are LINE-1 retrotransposon insertions common in colon cancer but less so in other tumor types?'4) Host evolution. Species exist in a dynamic state with respect to these genomic invaders, constantly redefining mechanisms of resistance to retrotransposition. To better understand how new retrotransposon challenges are met, we will evaluate several aspects of host response to newly introduced retrotransposons in two experimental systems. We will also use models of mammalian gene evolution to identify loci under positive (diversifying) selection involved in adaptive responses to endogenous retrotransposons. The co-evolution of hosts and retrotransposon parasites represents an important yet understudied aspect of retrotransposon biology. Together, investigators in these topic areas will define our Center for Systems Biology of Retrotransposition.

Public Health Relevance

The Center for Systems Biology of Retrotransposition will generate unique contributions to systems biology research. As described above, interactions between hosts and transposons are multifaceted and-intricate. Systems approaches hold promise for analyzing and integrating high throughput datasets scaled to capture the complexity of these interactions, as well as for modeling aspects of host-transposon relationships. We expect the field will provide unprecedented opportunities develop systems approaches and to understand and manipulate the vital, highly coordinated relationship between host and transposons in targeted ways.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZGM1-BBCB-9 (SB))
Program Officer
Janes, Daniel E
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
New York University
Schools of Medicine
New York
United States
Zip Code
Tang, Zuojian; Steranka, Jared P; Ma, Sisi et al. (2017) Human transposon insertion profiling: Analysis, visualization and identification of somatic LINE-1 insertions in ovarian cancer. Proc Natl Acad Sci U S A 114:E733-E740
Domanski, Michal; LaCava, John (2017) Affinity Purification of the RNA Degradation Complex, the Exosome, from HEK-293 Cells. Bio Protoc 7:
Payer, Lindsay M; Steranka, Jared P; Yang, Wan Rou et al. (2017) Structural variants caused by Alu insertions are associated with risks for many human diseases. Proc Natl Acad Sci U S A 114:E3984-E3992
Domanski, Michal; LaCava, John (2017) RNA Degradation Assay Using RNA Exosome Complexes, Affinity-purified from HEK-293 Cells. Bio Protoc 7:
McLaughlin Jr, Richard N; Malik, Harmit S (2017) Genetic conflicts: the usual suspects and beyond. J Exp Biol 220:6-17
Newkirk, Simon J; Lee, Suman; Grandi, Fiorella C et al. (2017) Intact piRNA pathway prevents L1 mobilization in male meiosis. Proc Natl Acad Sci U S A 114:E5635-E5644
Ortega-Del Vecchyo, Diego; Marsden, Clare D; Lohmueller, Kirk E (2016) PReFerSim: fast simulation of demography and selection under the Poisson Random Field model. Bioinformatics 32:3516-3518
Franks, Tobias M; Benner, Chris; Narvaiza, IƱigo et al. (2016) Evolution of a transcriptional regulator from a transmembrane nucleoporin. Genes Dev 30:1155-71
Mita, Paolo; Savas, Jeffrey N; Briggs, Erica M et al. (2016) URI Regulates KAP1 Phosphorylation and Transcriptional Repression via PP2A Phosphatase in Prostate Cancer Cells. J Biol Chem 291:25516-25528
Criscione, Steven W; Theodosakis, Nicholas; Micevic, Goran et al. (2016) Genome-wide characterization of human L1 antisense promoter-driven transcripts. BMC Genomics 17:463

Showing the most recent 10 out of 43 publications